Zylorion Health
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study (NCT05438758) | Zylorion Health | 2023-01-15 |
| Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression (NCT05323019) | Zylorion Health | 2022-10-13 |
Track Zylorion Health automatically
Every clearance here is in the API, with alerts when new ones post.